Back to Results
First PageMeta Content
Generally Accepted Accounting Principles / Financial statements / Financial accounting / Neglected diseases / Drugs for Neglected Diseases Initiative / ASAQ / Income statement / Balance sheet / Income / Accountancy / Finance / Business


Audit report 2011 for annual report
Add to Reading List

Document Date: 2012-08-07 05:24:52

Open Document

File Size: 1,15 MB

Share Result on Facebook

City

Tokyo / Geneva / Philadelphia / New York / /

Company

DNDi NA / Tait / Weller & Baker LLP / Sanofi / SSG / DNDi Latin America / /

Continent

Asia / Africa / /

Country

Kenya / France / United States / Uganda / Brazil / Bangladesh / Ethiopia / Sudan / /

Currency

BRL / USD / GBP / CHF / KES / EUR / INR / JPY / /

Event

Reorganization / /

Facility

Kenya Medical Research Institute / /

IndustryTerm

firm auditing / cash-flow management / pharmaceutical / /

Organization

Institut Pasteur / Gilead / Regional Office / Indian Council of Medical Research / DNDi’s mission / After Board / Kenya Medical Research Institute / International office of Médecins Sans Frontières / Computer Equipment Office / IDA Foundation / /

Position

Executive Director / the R&D Director / Prime Minister / CPA / Director for important and complex agreements and contracts exceeding EUR / Medical Director / Director / the Discovery & Pre-clinical Director / /

Product

AmBisome / /

ProvinceOrState

Pennsylvania / /

SocialTag